Literature DB >> 7796399

Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors.

L V Owens1, L Xu, R J Craven, G A Dent, T M Weiner, L Kornberg, E T Liu, W G Cance.   

Abstract

The focal adhesion kinase (FAK) gene encodes a tyrosine kinase (p125FAK) thought to be involved in signal transduction pathways used in cell adhesion, motility, and anchorage-independent growth. Because alterations in these cellular processes occur in tumor invasion and metastasis, we studied the protein expression of FAK in a variety of human tumors and found that in the 119 samples studied, increased levels of p125FAK correlated with the invasive potential of a tumor. By comparing FAK expression in tumors with normal tissue from the same patient, we found that p125FAK was significantly elevated in 17 (100%) of 17 invasive and metastatic colonic lesions and in 22 (88%) of 25 invasive and metastatic breast tumors. Additional studies of FAK expression in 13 high grade sarcomas showed high levels in all samples compared to benign, noninvasive mesenchymal specimens. Furthermore, FAK protein levels were elevated in preinvasive lesions, such as large (> 2 cm) colonic villous adenomas, whereas noninvasive, yet hypercellular, neoplastic tissues such as parathyroid and hepatocellular adenomas did not overexpress FAK. These data provide evidence that both epithelial and mesenchymal tumor progression are accompanied by increased p125FAK expression and suggest that the level of FAK expression might be a marker for the invasive potential of a tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  205 in total

Review 1.  Adhesion-mediated signaling in the regulation of mammary epithelial cell survival.

Authors:  C H Streuli; A P Gilmore
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 2.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 3.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

4.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly.

Authors:  Z S Zhao; E Manser; T H Loo; L Lim
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  Conformational dynamics of the focal adhesion targeting domain control specific functions of focal adhesion kinase in cells.

Authors:  Gress Kadaré; Nicolas Gervasi; Karen Brami-Cherrier; Heike Blockus; Said El Messari; Stefan T Arold; Jean-Antoine Girault
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

7.  Molecular characterization of human tensin.

Authors:  H Chen; A Ishii; W K Wong; L B Chen; S H Lo
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 8.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

9.  FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Authors:  Alexandros Garouniatis; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

10.  Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

Authors:  Carmelle V Romain; Pritha Paul; Sora Lee; Jingbo Qiao; Dai H Chung
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.